Digisonics and Medis partner to provide comprehensive pediatric and Adult Cardiovascular MR image review, analysis and structured reporting solution

Published on:

Digisonics and Medis are proud to announce a partnership to provide a comprehensive single system solution for image analysis and structured reporting of pediatric and adult CV MR studies. The integrated system solution between Digisonics and Medis will result in a seamless, efficient MR workflow.

Users will have access to fast image review and analysis of their MR studies via the Medis QMass® ES advanced quantitation software which provides built-in disease-oriented review layouts and cross referencing tools. Users can analyze cardiovascular dimensions and morphology, myocardial function (MR & CT), phase-contrast blood flow, tissue characterization (late enhancement, T2 weighted edema, T2/T2* mapping, T1 mapping), myocardial perfusion and MR angiography. Results from the analysis completed in Medis will be saved directly back into the Digisonics cardiovascular information system.

With the completed image analysis from Medis, clinicians can then quickly summarize their findings in a structured report using Digisonics’ easy-to-navigate picklists and summary macros. These concise (usually one-page) and highly-configurable reports also offer the ability to embed post-processed study images and graphics such as charts or clinical diagrams.

“Digisonics is excited to partner with Medis in offering the most comprehensive combination of Cardiac MR imaging and reporting functionality on the market,” said Steve Dissing, Director of Sales and Marketing at Digisonics.  “Combining Digisonics’ 39 years of experience in structured reporting with the MR imaging toolset from Medis will provide clinicians and researchers the comprehensive analysis, reporting and data mining capabilities they require.”

“This solution combines Digisonics’ outstanding reporting and data mining capabilities with our long-term available gold standard quantitative analysis and post processing tools providing a comprehensive and efficient solution for both clinicians and researchers,” said Daniel Garcia Miranda, VP Corporate Marketing & Sales at Medis.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
FDA clears AI screening tool for cardiac amyloidosis
IVUS-guided PCI reduces risks in patients with diabetes
SCCT leaders unpack the 2025 Medicare payment increase for coronary CTA
Global shortage of nuclear imaging isotopes may be over
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."